Cna Financial Corp Aerie Pharmaceuticals Inc Transaction History

Cna Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$11.84 - $25.52 $1.29 Million - $2.78 Million	-109,028 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.72 - $25.1 $1.2 Million - $1.69 Million	-67,497 Reduced 38.24%	109,028 $2.64 Million
Q3 2019 Nov 06, 2019	BUY	$18.41 - $28.0 $2.71 Million - $4.12 Million	147,094 Added 499.79%	176,525 $3.39 Million
Q2 2019 Aug 13, 2019	BUY	$28.97 - $48.21 $852,616 - $1.42 Million	29,431 New	29,431 $870,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.